Global Blood Takes HOPE In Sickle Cell After Pulmonary Fibrosis Failure

GBT440 is not efficacious enough in studies of idiopathic pulmonary fibrosis, but the drug was well-tolerated at twice the exposure in the treatment of sickle cell disease, the drug's lead indication.